TY  - GEN 
AU  - Blancas, Isabel
AU  - Linares‑Rodríguez, Marina
AU  - Martín‑Bravo, Celia
AU  - Gómez‑Peña, Celia
AU  - Rodríguez‑Serrano, Fernando
PY  - 2024
UR  - https://hdl.handle.net/10481/91957
AB  - Purpose HER2 overexpression in breast cancer correlates with poor outcomes. The incorporation of Trastuzumab into
the treatment regimen has notably improved patient prognoses. However, cardiotoxicity emerges in approximately 20% of
patients treated...
LA  - eng
PB  - Springer
KW  - Breast cancer
KW  - Trastuzumab
KW  - HER2 polymorphism
KW  - Cardiotoxicity
KW  - Survival
TI  - HER2/neu 655 polymorphism, trastuzumab‑induced cardiotoxicity, and survival in HER2‑positive breast cancer patients
DO  - https://doi.org/10.1007/s12094-024-03512-6
ER  -